Inclusive of all taxes
VIPASANA 100 Tablet by Dr Precision is a high-strength pharmaceutical formulation containing 100 mg of Sertraline, a selective serotonin reuptake inhibitor (SSRI) used in the treatment of various psychiatric disorders including major depressive disorder (MDD), generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), panic disorder, and social anxiety disorder. Manufactured in a WHO-GMP-certified facility, VIPASANA 100 ensures pharmaceutical-grade purity, stability, and bioavailability. It works by inhibiting serotonin reuptake in the brain, enhancing mood, reducing anxiety, and promoting emotional balance. Designed for consistent absorption with once-daily dosing, VIPASANA 100 is suitable for long-term management of mental health conditions. The formulation is packaged and labeled following global compliance norms, making it ideal for private labeling, contract manufacturing, and global distribution. The tablet's favorable efficacy and tolerability profile make it a reliable treatment option that healthcare providers trust for both acute and maintenance therapy of mood and anxiety disorders. Patient monitoring is advised due to potential side effects, and caution is necessary in special populations such as pregnant women or patients with liver dysfunction. VIPASANA 100 aligns with therapeutic objectives aimed at mental clarity and emotional healing, making it a strategic addition to any pharmaceutical portfolio focused on psychiatric care.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Sertraline 100 mg |
| Therapeutic Class | Selective Serotonin Reuptake Inhibitor (SSRI) |
| Indications | Depression, Anxiety Disorders, OCD, PTSD, Panic Disorder, Social Anxiety Disorder |
| Manufacturing Standards | WHO-GMP Certified Facility |
| Dosage Form | Oral Tablet |
| Dosage Frequency | Once Daily |
| Pharmaceutical Quality | Pharmaceutical-grade purity, stability, and bioavailability |
| Packaging | Secure packaging with global compliance labeling |
| Side Effects | Possible nausea, headache, insomnia, dizziness, gastrointestinal discomfort |
| Use Case | Suitable for private labeling, contract manufacturing, and global distribution |
| Attributes | Description |
|---|---|
| Active Pharmaceutical Ingredient | Sertraline |
| Strength | 100 mg per tablet |
| Formulation Type | Tablet |
| Pharmacological Action | Inhibits serotonin reuptake to enhance mood and emotional stability |
| Indication Spectrum | MDD, GAD, OCD, PTSD, Panic Disorder, Social Anxiety Disorder |
| Dosing Recommendations | Once daily, with or without food, dose adjustment based on clinical response |
| Manufacturing Compliance | WHO-GMP certified with adherence to international pharmaceutical standards |
| Stability and Shelf Life | Stable under recommended storage conditions as per global standards |
| Side Effect Profile | Generally well-tolerated; monitoring required for serious adverse events |
| Caution Points | Avoid with MAOIs, caution in liver dysfunction, epilepsy, pregnancy, breastfeeding |
| Packaging Specifications | Batch traceability and secure labeling for compliance |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, VIPASANA 100 is designed to be a reliable option for both acute and long-term maintenance therapy of depression and anxiety-related disorders due to its stable pharmacological profile and consistent bioavailability.
Yes, VIPASANA 100 is suitable for private labeling and contract manufacturing, with packaging and labeling customizable to meet the regulatory and market-specific requirements of various countries.
VIPASANA 100 should be stored as per global pharmaceutical storage standards—typically in a cool, dry place away from direct sunlight to ensure its shelf stability and potency.
Yes, caution is advised for patients with liver dysfunction, epilepsy, pregnant or breastfeeding women, and those taking monoamine oxidase inhibitors or other serotonergic agents. Close medical supervision is essential for these groups.
VIPASANA 100 is manufactured in a WHO-GMP-certified facility, ensuring compliance with international quality and safety standards for pharmaceutical production.
By inhibiting serotonin reuptake in the brain, VIPASANA 100 increases serotonin availability, which helps regulate mood, reduce anxiety, and promote emotional balance, leading to improved patient outcomes.
Noticeable improvements generally occur within two to four weeks of consistent daily use of VIPASANA 100 as prescribed.
Country Of Origin: India
VIPASANA 100 Tablet is a pharmaceutical formulation containing Sertraline 100 mg, an antidepressant belonging to the selective serotonin reuptake inhibitor (SSRI) class. It is used in the treatment of depression, anxiety disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and panic disorders by improving serotonin levels in the brain, helping stabilize mood and emotions.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
VIPASANA 100 Tablet is a high-strength formulation of Sertraline, a selective serotonin reuptake inhibitor (SSRI) prescribed for a range of psychiatric conditions including major depressive disorder (MDD), generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), panic disorder, post-traumatic stress disorder (PTSD), and social anxiety disorder. Each tablet contains 100 mg of Sertraline, a well-established and clinically proven active pharmaceutical ingredient that functions by inhibiting the reuptake of serotonin in the brain, thereby enhancing mood, reducing anxiety, and promoting emotional balance.
Sertraline is known for its favorable efficacy and tolerability profile and is often recommended for long-term management of depressive and anxiety-related conditions. VIPASANA 100 acts gradually, with noticeable improvements often appearing within two to four weeks of consistent use. It is typically taken once daily, with or without food, and its dosage may be adjusted by a healthcare provider depending on individual response and tolerability. As with most SSRIs, abrupt discontinuation should be avoided, and tapering is recommended when stopping treatment.
Manufactured in a state-of-the-art WHO-GMP-certified facility, VIPASANA 100 Tablet is produced with strict adherence to international quality standards, ensuring pharmaceutical-grade purity, stability, and bioavailability. The tablet is designed for consistent absorption and sustained therapeutic effect, making it a reliable treatment option for both acute and chronic phases of mental health management. The product is suitable for private labeling, contract manufacturing, and global distribution, and can be tailored to meet the regulatory and packaging requirements of various markets.
VIPASANA 100 is generally well-tolerated, though patients may experience temporary side effects such as nausea, headache, insomnia, dry mouth, dizziness, or gastrointestinal discomfort. In rare cases, more serious effects such as serotonin syndrome, suicidal thoughts, or manic episodes may occur, particularly at the start of treatment or after dose escalation. Therefore, patient monitoring is essential, especially in young adults and those with a history of bipolar disorder or substance use.
This medication should not be used in combination with monoamine oxidase inhibitors (MAOIs) or other serotonergic agents without proper medical oversight due to the risk of serotonin toxicity. Caution is advised in individuals with liver dysfunction, epilepsy, or seizure disorders. Pregnant or breastfeeding women should use VIPASANA 100 only under strict medical supervision when the potential benefits outweigh the risks.
The branding of VIPASANA reflects a commitment to mental clarity and emotional healing, aligning with the therapeutic objectives of Sertraline-based treatment. It serves as a dependable option in psychiatric care, trusted by physicians and patients alike. Whether used as part of an initial therapeutic plan or in maintenance therapy, VIPASANA 100 offers a clinically validated, high-quality solution for addressing mood and anxiety disorders with consistency and efficacy.
VIPASANA 100 is packaged securely and labeled according to global compliance norms, ensuring shelf stability, batch traceability, and patient safety. Its availability through third-party manufacturing and distribution models makes it a strategic addition to any pharmaceutical portfolio seeking to meet the rising demand for high-quality psychiatric medications. Its clinical performance, coupled with dependable manufacturing, makes VIPASANA 100 a product of choice for healthcare providers aiming to deliver long-term mental health support with confidence.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
